SODIUM PERTECHNETATE TC 99M Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Pertechnetate Tc 99m, and what generic alternatives are available?
Sodium Pertechnetate Tc 99m is a drug marketed by Ge Healthcare, Mallinckrodt, and Pharmalucence. and is included in three NDAs.
The generic ingredient in SODIUM PERTECHNETATE TC 99M is technetium tc-99m sodium pertechnetate. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate profile page.
Summary for SODIUM PERTECHNETATE TC 99M
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 3 |
Patent Applications: | 67 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM PERTECHNETATE TC 99M at DailyMed |
Recent Clinical Trials for SODIUM PERTECHNETATE TC 99M
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 1 |
National Cancer Institute (NCI) | Phase 1 |
Endocyte | Phase 1 |